New CMS Demo Aims to Increase Access to GLP-1s Under Medicaid and Part D

(MedPage Today) -- The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how popular or effective it will...